outcome assessment, health care

Evaluating the real-world effectiveness of belimumab in patients with SLE using SLE-related laboratory values and rheumatoid arthritis-derived disease activity measures: RAPID3, swollen joint count and tender joint count
Guillaume Germain, Karen Worley, Sean D MacKnight, Bernard Rubin, Christopher F Bell, François Laliberté, Ana Urosevic, Mei Sheng Duh, Andrew Concoff

Lupus Science & Medicine Apr 2024, 11 (1) e001111; DOI: 10.1136/lupus-2023-001111
Association of phenotypic frailty and hand grip strength with telomere length in SLE
Sarah B Lieber, Robyn A Lipschultz, Shahrez Syed, Mangala Rajan, Sara Venkatraman, Myriam Lin, M Carrington Reid, Neal F Lue, Lisa A Mandl

Lupus Science & Medicine Mar 2024, 11 (1) e001008; DOI: 10.1136/lupus-2023-001008
Differences in reproductive health discussions in an urban Hispanic population with SLE: lessons from the field
Martha Delgado, Jack Rodman, Meredith Xepoleas, Michael Weisman, Leanna Marderian Wise

Lupus Science & Medicine Feb 2024, 11 (1) e001095; DOI: 10.1136/lupus-2023-001095
Protocol for virtual physical examination in an observational, longitudinal study evaluating virtual outcome measures in SLE
Anca D Askanase, Cynthia Aranow, Mimi Y Kim, Diane L Kamen, Cristina Arriens, Leila Khalili, Wei Tang, Julia Barasch, Maria Dall'Era, Meggan Mackay

Lupus Science & Medicine Jul 2023, 10 (2) e000952; DOI: 10.1136/lupus-2023-000952
Centrally acting ACE inhibitor (cACEi) and angiotensin receptor blocker (cARB) use and cognitive dysfunction in patients with SLE
Chrisanna Dobrowolski, Michelle Barraclough, Jiandong Su, Milica Tanic, Kathleen Bingham, Lesley Ruttan, Dorcas Beaton, Joan Wither, Maria Carmela Tartaglia, Mary Sano, Mahta Kakvan, Dennisse Bonilla, Robin Green, Zahi Touma

Lupus Science & Medicine Jul 2023, 10 (2) e000923; DOI: 10.1136/lupus-2023-000923
Serum interferon-alpha predicts in-hospital mortality in patients hospitalised with acute severe lupus
Keerthi Vardhan Yerram, Ritasman Baisya, Phani Kumar, Rammohan Mylavarapu, Liza Rajasekhar

Lupus Science & Medicine Sep 2023, 10 (2) e000933; DOI: 10.1136/lupus-2023-000933
Selection of indicators reporting response rate in pharmaceutical trials for systemic lupus erythematosus: preference and relative sensitivity
Jingru Tian, Shuntong Kang, Dingyao Zhang, Yaqing Huang, Xu Yao, Ming Zhao, Qianjin Lu

Lupus Science & Medicine Oct 2023, 10 (2) e000942; DOI: 10.1136/lupus-2023-000942
Muscle strength, not muscle mass, determines the health-related quality of life in Indonesian women with systemic lupus erythematosus
Stevent Sumantri, Euphemia Seto, Iris Rengganis

Lupus Science & Medicine Nov 2023, 10 (2) e001025; DOI: 10.1136/lupus-2023-001025
Development and psychometric evaluation of a physician global assessment for type 2 systemic lupus erythematosus symptoms
Megan E B Clowse, Jennifer L Rogers, Theresa Coles, David S Pisetsky, Lisa G Criscione-Schreiber, Dana Burshell, Jayanth Doss, Rebecca E Sadun, Kai Sun, Mithu Maheswaranathan, Amanda M Eudy

Lupus Science & Medicine Dec 2023, 10 (2) e001016; DOI: 10.1136/lupus-2023-001016
Clarifying misbeliefs about hydroxychloroquine (HCQ): developing the HCQ benefits versus harm decision aid (HCQ-SAFE) per low health literacy standards
Shivani Garg, Sancia Ferguson, Betty Chewning, Shelby Gomez, Jon Keevil, Christie Bartels

Lupus Science & Medicine Jul 2023, 10 (2) e000935; DOI: 10.1136/lupus-2023-000935

Main menu

outcome assessment, health care

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

outcome assessment, health care

Pages